Financials
- Fiscal year
- 2025
- Total assets
- €614,858
- Loss
- -€112,410
- Solvency
- 78.6%
REVATIS VET
ActiveSummary
REVATIS VET has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €483,081 and a net result of -€112,410. Its solvency ranks better than 80% of 13501 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Overview
Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
1 site
Size
€614,858total assets 2025
- Equity
- €483,081
- Loss
- -€112,410
Turnover not published (abridged schema)
Structure
Accounts 10 d early1 of 4 deeds read
Why 71- Founded in 2024- Loss of €112,410 (FY 2025)+ Size: total assets €614,858+ Figures for FY 2025 (filed 23-07-2026)Show the evidence
Checked score
Score 2025
71
/ 100
Healthy
Probability in this band: 0.55% to 1.5%
Better than 64% of its sector peers (NACE 46, micro)
Performance against the sector, not lower risk
Financial strength
Strong
Solvency
100
equity 78.6% of total assets
Liquidity
57
short-term debt 21.4% · cash 11.6%
Profitability
50
return on assets -18.3%
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2025: 1.6%
01-2026: 1.7%▲ +2.7% vs 12-2025
02-2026: 2.0%▲ +19.6% vs 01-2026
03-2026: 2.1%▲ +5.3% vs 02-2026
04-2026: 2.3%▲ +11.1% vs 03-2026
05-2026: 2.3%● 0.0% vs 04-2026
06-2026: 2.6%▲ +10.3% vs 05-2026
07-2026: 2.6%▲ +1.9% vs 06-2026highest value
08-2026: 0.6%▼ -76.6% vs 07-2026
09-2026: 0.6%▼ -1.5% vs 08-2026lowest value
10-2026: 0.6%▲ +4.1% vs 09-2026
- Founded in 2024 raises the probability for this profile
- Loss of €112,410 (FY 2025) raises the probability
- Size: total assets €614,858 lowers the probability for this profile
- Figures for FY 2025 (filed 23-07-2026) lowers the probability
Credit up to €30,000 at 30 days only on tighter terms
Liquidity ample (current ratio 2.59; short-term debt: 21.4% and cash: 11.6% of total assets), and 21.4% of the assets are financed with debt.
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 46, micro). Better than this share of them on solvency 90%, liquidity 63%, profitability 39%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 04-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 21-07-2026, 10 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
10 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
- Resignation: Shatal BV (director)Permanent representative: Tom Mariën ·…
- Annual accounts filedfiscal year 2025 · micro…
Key points
By topic
Timeline
- Events
- 2
- Since
- 2026
- 24-07-2026Resignation: Shatal BV (director)
- 21-07-2026Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460
- Founded
- 04-11-2024
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.